Corteva (NYSE:CTVA) Issues Earnings Results

Corteva (NYSE:CTVA) posted its earnings results on Wednesday. The company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by ($0.02), Zacks reports. Corteva had a return on equity of 6.63% and a net margin of 4.18%. Corteva updated its FY 2025 guidance to 2.700-2.950 EPS.

Corteva Stock Up 2.7 %

Shares of CTVA traded up $1.69 on Friday, hitting $64.05. The company’s stock had a trading volume of 151,538 shares, compared to its average volume of 3,586,620. The company has a quick ratio of 0.96, a current ratio of 1.50 and a debt-to-equity ratio of 0.08. The firm has a market capitalization of $44.02 billion, a price-to-earnings ratio of 64.72, a P/E/G ratio of 1.71 and a beta of 0.78. Corteva has a fifty-two week low of $50.01 and a fifty-two week high of $66.24. The firm’s fifty day moving average price is $60.22 and its 200-day moving average price is $58.14.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 3rd will be issued a $0.17 dividend. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a yield of 1.06%. Corteva’s dividend payout ratio is presently 68.69%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CTVA. Bank of America upped their target price on Corteva from $67.00 to $69.00 and gave the company a “buy” rating in a research report on Wednesday, November 20th. Wells Fargo & Company raised their price target on Corteva from $67.00 to $73.00 and gave the company an “overweight” rating in a research report on Tuesday, January 28th. UBS Group reduced their price objective on Corteva from $74.00 to $73.00 and set a “buy” rating on the stock in a research report on Friday, January 10th. Barclays boosted their price target on Corteva from $62.00 to $64.00 and gave the company an “equal weight” rating in a report on Tuesday, January 21st. Finally, Royal Bank of Canada increased their price objective on shares of Corteva from $68.00 to $73.00 and gave the stock an “outperform” rating in a report on Thursday, December 19th. One analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $67.06.

Corteva declared that its board has authorized a stock buyback program on Tuesday, November 19th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the company to purchase up to 7.5% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its stock is undervalued.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.